These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 24533719)

  • 1. Inhibition of coagulation factor Xa improves myocardial function during CVB3-induced myocarditis.
    Malz R; Weithauser A; Tschöpe C; Schultheiss HP; Rauch U
    Cardiovasc Ther; 2014 Jun; 32(3):113-9. PubMed ID: 24533719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulation by interleukin-4 suppresses matrix metalloproteinases and improves cardiac function in murine myocarditis.
    Li J; Leschka S; Rutschow S; Schwimmbeck PL; Husmann L; Noutsias M; Westermann D; Poller W; Zeichhardt H; Klingel K; Tschope C; Schultheiss HP; Pauschinger M
    Eur J Pharmacol; 2007 Jan; 554(1):60-8. PubMed ID: 17113076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adiponectin promotes coxsackievirus B3 myocarditis by suppression of acute anti-viral immune responses.
    Jenke A; Holzhauser L; Löbel M; Savvatis K; Wilk S; Weithäuser A; Pinkert S; Tschöpe C; Klingel K; Poller W; Scheibenbogen C; Schultheiss HP; Skurk C
    Basic Res Cardiol; 2014 May; 109(3):408. PubMed ID: 24691762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host.
    Szalay G; Sauter M; Haberland M; Zuegel U; Steinmeyer A; Kandolf R; Klingel K
    Circ Res; 2009 Apr; 104(7):851-9. PubMed ID: 19246678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced degradation of the chemokine MCP-3 by matrix metalloproteinase-2 exacerbates myocardial inflammation in experimental viral cardiomyopathy.
    Westermann D; Savvatis K; Lindner D; Zietsch C; Becher PM; Hammer E; Heimesaat MM; Bereswill S; Völker U; Escher F; Riad A; Plendl J; Klingel K; Poller W; Schultheiss HP; Tschöpe C
    Circulation; 2011 Nov; 124(19):2082-93. PubMed ID: 21986287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carvedilol improves left ventricular function in murine coxsackievirus-induced acute myocarditis association with reduced myocardial interleukin-1beta and MMP-8 expression and a modulated immune response.
    Pauschinger M; Rutschow S; Chandrasekharan K; Westermann D; Weitz A; Peter Schwimmbeck L; Zeichhardt H; Poller W; Noutsias M; Li J; Schultheiss HP; Tschope C
    Eur J Heart Fail; 2005 Jun; 7(4):444-52. PubMed ID: 15921778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Treatment of Coxsackievirus B3-Infected Animals With Soluble Coxsackievirus-Adenovirus Receptor Inhibits Development of Chronic Coxsackievirus B3 Cardiomyopathy.
    Pinkert S; Dieringer B; Klopfleisch R; Savvatis K; Van Linthout S; Pryshliak M; Tschöpe C; Klingel K; Kurreck J; Beling A; Fechner H
    Circ Heart Fail; 2019 Nov; 12(11):e005250. PubMed ID: 31718319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular enlargement in coxsackievirus-B3 induced chronic myocarditis--ongoing inflammation and an imbalance of the matrix degrading system.
    Rutschow S; Leschka S; Westermann D; Puhl K; Weitz A; Ladyszenskij L; Jaeger S; Zeichhardt H; Noutsias M; Schultheiss HP; Tschope C; Pauschinger M
    Eur J Pharmacol; 2010 Mar; 630(1-3):145-51. PubMed ID: 20035743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenic Role of the Damage-Associated Molecular Patterns S100A8 and S100A9 in Coxsackievirus B3-Induced Myocarditis.
    Müller I; Vogl T; Pappritz K; Miteva K; Savvatis K; Rohde D; Most P; Lassner D; Pieske B; Kühl U; Van Linthout S; Tschöpe C
    Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29158436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral activity of coxsackievirus B3 3C protease inhibitor in experimental murine myocarditis.
    Yun SH; Lee WG; Kim YC; Ju ES; Lim BK; Choi JO; Kim DK; Jeon ES
    J Infect Dis; 2012 Feb; 205(3):491-7. PubMed ID: 22207647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis.
    Zhou L; He X; Gao B; Xiong S
    J Virol; 2015 Oct; 89(20):10512-23. PubMed ID: 26269170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in coxsackievirus-induced myocarditis.
    Cheung C; Luo H; Yanagawa B; Leong HS; Samarasekera D; Lai JC; Suarez A; Zhang J; McManus BM
    Cardiovasc Pathol; 2006; 15(2):63-74. PubMed ID: 16533694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis.
    Heymans S; Pauschinger M; De Palma A; Kallwellis-Opara A; Rutschow S; Swinnen M; Vanhoutte D; Gao F; Torpai R; Baker AH; Padalko E; Neyts J; Schultheiss HP; Van de Werf F; Carmeliet P; Pinto YM
    Circulation; 2006 Aug; 114(6):565-73. PubMed ID: 16880329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclophilin A affects inflammation, virus elimination and myocardial fibrosis in coxsackievirus B3-induced myocarditis.
    Seizer P; Klingel K; Sauter M; Westermann D; Ochmann C; Schönberger T; Schleicher R; Stellos K; Schmidt EM; Borst O; Bigalke B; Kandolf R; Langer H; Gawaz M; May AE
    J Mol Cell Cardiol; 2012 Jul; 53(1):6-14. PubMed ID: 22446162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CX3CR1 knockout aggravates Coxsackievirus B3-induced myocarditis.
    Müller I; Pappritz K; Savvatis K; Puhl K; Dong F; El-Shafeey M; Hamdani N; Hamann I; Noutsias M; Infante-Duarte C; Linke WA; Van Linthout S; Tschöpe C
    PLoS One; 2017; 12(8):e0182643. PubMed ID: 28800592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralizing anti-4-1BBL treatment improves cardiac function in viral myocarditis.
    Cheung CT; Deisher TA; Luo H; Yanagawa B; Bonigut S; Samra A; Zhao H; Walker EK; McManus BM
    Lab Invest; 2007 Jul; 87(7):651-61. PubMed ID: 17468777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of RNA interference and virus receptor trap exerts additive antiviral activity in coxsackievirus B3-induced myocarditis in mice.
    Stein EA; Pinkert S; Becher PM; Geisler A; Zeichhardt H; Klopfleisch R; Poller W; Tschöpe C; Lassner D; Fechner H; Kurreck J
    J Infect Dis; 2015 Feb; 211(4):613-22. PubMed ID: 25193982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QiHong prevents death in coxsackievirus B3 induced murine myocarditis through inhibition of virus attachment and penetration.
    Song X; Liu Z; Wang H; Xin Y; Wang X; Chen J; Shi Y; Zhang C; Hui R
    Exp Biol Med (Maywood); 2007 Dec; 232(11):1441-8. PubMed ID: 18040068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the factor Xa inhibitor, fondaparinux, on the stability of atherosclerotic lesions in apolipoprotein E-deficient mice.
    Zuo P; Zhou Q; Zuo Z; Wang X; Chen L; Ma G
    Circ J; 2015; 79(11):2499-508. PubMed ID: 26346031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential macrophage polarization in male and female BALB/c mice infected with coxsackievirus B3 defines susceptibility to viral myocarditis.
    Li K; Xu W; Guo Q; Jiang Z; Wang P; Yue Y; Xiong S
    Circ Res; 2009 Aug; 105(4):353-64. PubMed ID: 19608981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.